Jing Wang

机构：Shanxi University, Academy of Military Medical Sciences, State Key Laboratory of Cryptology, Shanxi Normal University, Jingzhou Central Hospital, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-9076-5140

发表论文 76 篇 · 总被引 1426 次 · h-index 23

代表论文

• Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B (2022 · Journal of Hepatology · 被引 72)
• Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial (2022 · Journal of Ethnopharmacology · 被引 22)
• The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis (2023 · Hepatology · 被引 12)
• Targeting DNA Damage Repair to Enhance Antitumor Immunity in Radiotherapy: Mechanisms and Opportunities (2025 · International Journal of Molecular Sciences · 被引 11)
• Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues (2022 · The Journal of Infectious Diseases · 被引 11)
• Impact of maternal hepatitis B carrier status on congenital abnormalities: a systematic review and meta-analysis (2023 · BMJ Open · 被引 9)